Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapies
Abstract Given that many antifungal medications are susceptible to evolved resistance, there is a need for novel drugs with unique mechanisms of action. Inhibiting the essential proton pump Pma1p, a P-type ATPase, is a potentially effective therapeutic approach that is orthogonal to existing treatme...
Main Authors: | Sabine Ottilie, Gregory M. Goldgof, Andrea L. Cheung, Jennifer L. Walker, Edgar Vigil, Kenneth E. Allen, Yevgeniya Antonova-Koch, Carolyn W. Slayman, Yo Suzuki, Jacob D. Durrant |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Journal of Cheminformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13321-018-0261-3 |
Similar Items
-
A new pma1 mutation identified in a chronologically long-lived fission yeast mutant
by: Chikako Naito, et al.
Published: (2014-01-01) -
Lactoferrin perturbs lipid rafts and requires integrity of Pma1p-lipid rafts association to exert its antifungal activity against Saccharomyces cerevisiae
by: Andrés, M.T, et al.
Published: (2021) -
PMA: Protein Microarray Analyser, a user-friendly tool for data processing and normalization
by: Jessica Da Gama Duarte, et al.
Published: (2018-02-01) -
Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR
by: Sarah Tavernier, et al.
Published: (2015-02-01) -
Reversible Dissoziation der V-ATPase bei der Hefe Saccharomyces cerevisiae
by: Albertmelcher, Andrea
Published: (2010)